HEMAFER
Country: Israel
Language: English
Source: Ministry of Health
Patient Information leaflet
(PIL)
12-09-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FERRIC HYDROXIDE POLYMALTOSE COMPLEX AS
Available from:
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES LTD.
ATC code:
B03AB04
Pharmaceutical form:
DROPS
Composition:
FERRIC HYDROXIDE POLYMALTOSE COMPLEX AS 50 MG/ML
Administration route:
PER OS
Prescription type:
Not required
Manufactured by:
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A., GREECE
Therapeutic group:
FERRIC HYDROXIDE
Therapeutic area:
FERRIC HYDROXIDE
Therapeutic indications:
Prevention and treatment of iron deficiency anaemia.
Authorization date:
2018-08-31
Patient Information leaflet
.תשפיחש המ תא ונאצמ אל
הנוכנ תנזהש תבותכה םא קודבל יאדכ
תבותכב עייסל חמשנ
info@gov.il
(
1
)
Read the complete document
